A Study of Efavirenz in Combination With Stavudine and Didanosine
NCT00002225 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus didanosine to HIV-infected patients who have never received anti-HIV treatment.
Conditions
- HIV Infections
Interventions
- DRUG
-
Efavirenz
- DRUG
-
Stavudine
- DRUG
-
Didanosine
Sponsors & Collaborators
-
Dupont Merck
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
NCT00002235 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MKC-442 in Combination With Other Anti-HIV Drugs
NCT00002412 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002418 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
NCT00000919 ·Status: COMPLETED ·Phase: NA
-
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
NCT00002354 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002420 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00005000 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002234 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
NCT00001087 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
NCT00002419 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
NCT00005918 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
NCT00002176 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
NCT00004585 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
NCT00002224 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
NCT00002177 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
NCT00000939 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
NCT00002211 ·Status: COMPLETED ·Phase: NA
-
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
NCT00924898 ·Status: COMPLETED ·Phase: PHASE4
-
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
NCT00001758 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002362 ·Status: SUSPENDED ·Phase: PHASE3
-
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
NCT00006494 ·Status: COMPLETED
-
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
NCT00543725 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers
NCT00992069 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
NCT00007202 ·Status: COMPLETED ·Phase: PHASE2